Can prospect theory explain risk-seeking behavior by terminally ill patients?

Medical Decision Making

Volumn 25, Issue 6, 2005, Pages 609-613

  Rasiel, Emma B ^a,b   Weinfurt, Kevin P ^a   Schulman, Kevin A ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Decision theory; Life expectancy; Risk taking; Terminally ill

Indexed keywords

HEALTH BEHAVIOR; HUMAN; LIFE EXPECTANCY; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PROSPECT THEORY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TERMINALLY ILL PATIENT; THEORY;

DECISION MAKING; HUMANS; MODELS, THEORETICAL; RISK-TAKING; TERMINALLY ILL;

EID: 27944483275     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X05282642     Document Type: Review

References (14)

1. Tversky A, Kahneman D. Advances in prospect theory: cumulative representation of uncertainty. J Risk Uncertain. 1992;5:297-323.
2. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47:263-91.
3. Hastie R, Dawes RM. Rational Choice in an Uncertain World: The Psychology of Judgment and Decision Making. Thousand Oaks: Sage; 2001.
4. Stiggelbout AM, Klebert GM, Kievit J, Leer JWH, Stoter G, De Haes JCJM. Utility assessment of cancer patients: adjustments of time tradeoff scores for the utility of life years and comparison with standard gamble scores. Med Decis Making. 1994;14:82-90.
5. Mazur DJ, Hickam DH. Patient preferences: survival vs quality-of-life considerations. J Gen Intern Med. 1993;8:374-7.
6. Yaniv G. Withholding information from cancer patients as a physician's decision under risk. Med Decis Making. 2000;20:216-27.
7. Lenert LA, Treadwell JR, Schwartz CE. Associations between health status and utilities: implications for policy. Med Care. 1999;37:479-89.
8. O'Connor A. Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol. 1989;42:119-26.
9. Meropol NJ, Weinfurt KP, Burnett CB, et al. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol. 2004;21:2589-96.
10. Gaskin DJ, Weinfurt KP, Castel LD, et al. An exploration of relative health stock in advanced cancer patients. Med Decis Making. 2004;24:614-24.
11. Miyamoto JM, Eraker SA. A multiplicative model of the utility of survival duration and health quality. J Exp Psychol Gen. 1988;117:3-20.
12. Dolan P. The effect of experience of illness on health state valuations. J Clin Epidemiol. 1997;49:551-64.
13. Christensen-Szalanski JJ. Discount functions and the measurement of patients' values: women's decisions during childbirth. Med Decis Making. 1984;4:47-58.
14. Langer AS. Side effects, quality-of-life issues, and trade-offs: the patient perspective. J Natl Cancer Inst Monogr. 2001;30:125-9.